Norepinephrine-Levarterenol-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁
Norepinephrine-Levarterenol-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁
Norepinephrine-Levarterenol-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemENorepinephrineCat. No.: HY-13715CAS No.: 51-41-2Synonyms: Levarterenol; L-Noradrenaline分式: CHNO分量: 169.18作靶點: Endogenous Metabolite; Adrenergic Receptor; Autophagy作通路: Metabolic Enzyme/Protease; GPCR/G Protein; NeuronalSignaling

2、; Autophagy儲存式: 4C, protect from light, stored under nitrogen* In solvent : -80C, 6 months; -20C, 1 month (protect fromlight, stored under nitrogen)溶解性數(shù)據(jù)體外實驗 H2O : 5 mg/mL (29.55 mM; Need ultrasonic)DMSO : 5 mg/mL (29.55 mM; ultrasonic and warming and heat to 60C)Mass Solvent1 mg 5 mg 10 mg Concentr

3、ation制備儲備液1 mM 5.9109 mL 29.5543 mL 59.1086 mL5 mM 1.1822 mL 5.9109 mL 11.8217 mL10 mM 0.5911 mL 2.9554 mL 5.9109 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Norepinephrine (Levarterenol) 為 1選擇性的adrenergic receptor激動劑,EC50值為 5.37 M。IC50 & Target Human Endogenous Metabolite體外

4、研究Norepinephrine (NE) bitartrate monohydrate is generally considered to be a 1-subtype selective adrenergic1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemEagonist. Norepinephrine(NE) also has direct activity at the 2-adrenoceptor in higher concentrations 1.Adipocytes from the inguinal fat pad (iWA)

5、 or the interscapular fat pad (BA) are isolated from neonatal wild-type C57BL/6J mice and cultured. To examine the effect of activating AT2 upon -adrenergic signaling,cAMP production is first assessed in response to Norepinephrine (NE, 10 M) with or without CGP (10 nM)co-treatment. Norepinephrine (N

6、E) increases cAMP as expected in iWA, and CGP does not alter this effect.Norepinephrine (NE) is also known to induce lipolysis, and liberated fatty acids are required to functionallyactivate UCP1 protein and to stimulate heat production. CREB phosphorylation at Ser133 is increased afterNorepinephrin

7、e (NE) treatment and significantly attenuated with CGP co-treatment in mouse iWA 2.PROTOCOLCell Assay 2 Subcutaneous preadipocytes derived from a 38-year old non-diabetic female donor are immortalized withTERT and HPV E6/E7. For the current studies, a stable diploid clone (referred to as clone B) wi

8、th consistentdifferentiation capacity is isolated by ring cloning. Cells are grown in preadipocyte PGM2 media. Once cellsare confluent, differentiation is induced by incubation in differentiation media consisting of dexamethasone,IBMX, indomethacin, and additional insulin. Cells are differentiated f

9、or 10 days. Prior to treatment, media isreplaced with PGM2 media for one day and then switched to serum-free media overnight for treatments.Adipocytes are treated for 6 hours with vehicle, Norepinephrine (NE, 10 M), CGP (10 nM), orNorepinephrine (NE) and CGP 2.MCE has not independently confirmed the

10、 accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Cardiovasc Res. 2018 Feb 1;114(2):300-311. J Am Heart Assoc. 2019 Jan 8;8(1):e009871. J Nutr Biochem. 2018 May 1;58:110-118. Neuroscience. 2019 Mar 1;401:59-72. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:220-227

11、.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. MacGregor DA, et al. Relative efficacy and potency of beta-adrenoceptor agonists for generating cAMP in human lymphocytes. Chest.1996 Jan;109(1):194-200.2. Littlejohn NK, et al. Suppression of Resting Metabolism by the Angiotensin AT2 Receptor. Cell Rep. 2016 Aug 9;16(6):1548-60.McePdfHeightCaution: Product has n

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論